Ariadna Bargiela
-
- Genetic Neurodegenerative Diseases 15
-
- Muscle Physiology and Disorders 12
- Mitochondrial Function and Pathology 4
- CRISPR and Genetic Engineering 2
- Fungal and yeast genetics research 2
- RNA Research and Splicing 2
-
- Autophagy in Disease and Therapy 6
-
- Calpain Protease Function and Regulation 1
- Co-authors
- Rubén ArteroMaría Sabater-ArcisBeatriz LlamusíJuan M. Fernández‐CostaEstefanía Cerro-HerrerosJuan J. VílchezDenis FurlingMiren Zulaica
- Journals
- Proceedings of the National Academy of Sciences (1 paper)PLoS ONE (2 papers)Scientific Reports (2 papers)
- Partner nations
- SpainFranceUnited Kingdom
In The Last Decade
Ariadna Bargiela
16 papers receiving 289 citations
Peers
Comparison fields: 5 of 45
- Cellular and Molecular Neuroscience 171
- Aging 12
- Molecular Biology 245
- Neurology 34
- Genetics 20
Countries citing papers authored by Ariadna Bargiela
This map shows the geographic impact of Ariadna Bargiela's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ariadna Bargiela with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ariadna Bargiela more than expected).
Fields of papers citing papers by Ariadna Bargiela
This network shows the impact of papers produced by Ariadna Bargiela. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ariadna Bargiela. The network helps show where Ariadna Bargiela may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ariadna Bargiela, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 4 | |
| 7 | 2021 | 16 | |
| 8 | 2021 | 0 | |
| 9 | 2021 | 0 | |
| 10 | 2021 | 15 | |
| 11 | 2021 | 9 | |
| 12 | 2020 | 52 | |
| 13 | 2019 | 35 | |
| 14 | 2019 | 33 | |
| 15 | 2016 | 6 | |
| 16 | 2015 | 62 | |
| 17 | 2014 | 13 | |
| 18 | 2012 | 35 | |
| 19 | 2010 | 1 |
About Ariadna Bargiela
Ariadna Bargiela is a scholar working on Cellular and Molecular Neuroscience, Aging and Geriatrics and Gerontology, having authored 19 papers that have together received 290 indexed citations. Recurring topics across this work include Genetic Neurodegenerative Diseases (15 papers), Muscle Physiology and Disorders (12 papers), Autophagy in Disease and Therapy (6 papers), Mitochondrial Function and Pathology (4 papers), CRISPR and Genetic Engineering (2 papers), Fungal and yeast genetics research (2 papers), RNA Research and Splicing (2 papers) and Calpain Protease Function and Regulation (1 paper). The work is most often cited by research in Cellular and Molecular Neuroscience (171 citations), Aging (12 citations) and Molecular Biology (245 citations). Ariadna Bargiela has collaborated with scholars based in Spain, France and United Kingdom. Frequent co-authors include Rubén Artero, María Sabater-Arcis, Beatriz Llamusí, Juan M. Fernández‐Costa, Estefanía Cerro-Herreros, Juan J. Vílchez, Denis Furling, Miren Zulaica, Adolfo López de Munaín and Amparo García-López. Their work appears in journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.